FDA Inspection 1302418 — American National Red Cross

American National Red Cross — FEI 3003008582

The FDA completed an inspection of American National Red Cross on January 21, 2026 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 21, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Minneapolis, MN (United States)